Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty
BioPlus Acquisition Corp (BIOS)
The entity has a beta of 0.0156. As returns on the market increase, BioPlus Acquisition's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioPlus Acquisition is expected to be smaller as well. The beta indicator helps investors understand whether BioPlus Acquisition moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if BioPlus deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns. The firm currently falls under 'Small-Cap' category with a current market capitalization of 208.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPlus Acquisition's market, we take the total number of its shares issued and multiply it by BioPlus Acquisition's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Addus HomeCare (ADUS)
The company has return on total asset (ROA) of 0.0618 % which means that it generated a profit of $0.0618 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0933 %, meaning that it created $0.0933 on every $100 dollars invested by stockholders. Addus HomeCare's management efficiency ratios could be used to measure how well Addus HomeCare manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.24 in 2024, whereas Return On Capital Employed is likely to drop 0.07 in 2024. At this time, Addus HomeCare's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 865.6 M in 2024, whereas Other Current Assets are likely to drop slightly above 11.4 M in 2024. The firm currently falls under 'Mid-Cap' category with a current market capitalization of 1.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Addus HomeCare's market, we take the total number of its shares issued and multiply it by Addus HomeCare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
The company has return on total asset (ROA) of 0.0612 % which means that it generated a profit of $0.0612 on every $100 spent on assets. This is way below average. Acadia Healthcare's management efficiency ratios could be used to measure how well Acadia Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.0067. In addition to that, Return On Capital Employed is expected to decline to 0.06. At present, Acadia Healthcare's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 52.5 M, whereas Total Assets are forecasted to decline to about 4.4 B. This firm currently falls under 'Mid-Cap' category with a current market capitalization of 6.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acadia Healthcare's market, we take the total number of its shares issued and multiply it by Acadia Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Acadia Healthcare shows a prevailing Real Value of $82.5 per share. The current price of the firm is $71.19. Our model approximates the value of Acadia Healthcare from analyzing the firm fundamentals such as return on equity of -0.0054, and Profit Margin of (0.01) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Natera Inc (NTRA)
The company has return on total asset (ROA) of (0.1967) % which means that it has lost $0.1967 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5911) %, meaning that it created substantial loss on money invested by shareholders. Natera's management efficiency ratios could be used to measure how well Natera manages its routine affairs as well as how well it operates its assets and liabilities. As of April 25, 2024, Return On Tangible Assets is expected to decline to -0.31. In addition to that, Return On Capital Employed is expected to decline to -0.41. At present, Natera's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 208.5 M, whereas Other Assets are forecasted to decline to about 11.3 M. The firm currently falls under 'Large-Cap' category with a current market capitalization of 11.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Natera's market, we take the total number of its shares issued and multiply it by Natera's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
464.09 Million
At present, Natera's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
LHC Group (LHCG)
The company has return on total asset (ROA) of 0.0312 % which means that it generated a profit of $0.0312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0486 %, meaning that it created $0.0486 on every $100 dollars invested by stockholders. LHC's management efficiency ratios could be used to measure how well LHC manages its routine affairs as well as how well it operates its assets and liabilities. The firm currently falls under 'Mid-Cap' category with a current market capitalization of 5.27 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LHC's market, we take the total number of its shares issued and multiply it by LHC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
National HealthCare (NHC)
The company has Return on Asset of 0.0248 % which means that on every $100 spent on assets, it made $0.0248 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.073 %, implying that it generated $0.073 on every 100 dollars invested. National HealthCare's management efficiency ratios could be used to measure how well National HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, National HealthCare's Return On Assets are projected to slightly decrease based on the last few years of reporting. At present, National HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.14, whereas Total Assets are forecasted to decline to about 772 M. The firm currently falls under 'Mid-Cap' category with a total capitalization of 1.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate National HealthCare's market, we take the total number of its shares issued and multiply it by National HealthCare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
76.5 Million
At present, National HealthCare's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
HCA Holdings (HCA)
HCA Holdings [HCA] is traded in USA and was established null. HCA Holdings is listed under Health Care Providers & Services category by Fama And French industry classification. The fund is classified under Health Care category within Health Care Providers & Services family. The entity is thematically classified as Obamacare Repeal. HCA Holdings currently have 56.21 B in assets under management (AUM). with the current yeild of 0.01%. At this time, the entity appears to be overvalued. HCA Holdings owns a latest Real Value of $304.59 per share. The recent price of the entity is $319.02. Our model calculates the value of HCA Holdings from evaluating the entity fundamentals such as Return On Asset of 0.11, shares outstanding of 264.48 M, and Operating Margin of 0.16 % as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage taking in undervalued equities and trading overvalued equities since, at some future date, asset prices and their ongoing real values will blend.
Quest Diagnostics Incorporated (DGX)
The company has Return on Asset of 0.0621 % which means that on every $100 spent on assets, it made $0.0621 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1462 %, implying that it generated $0.1462 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.14 in 2024. Return On Capital Employed is likely to drop to 0.10 in 2024. At this time, Quest Diagnostics' Other Assets are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.99 in 2024, whereas Total Assets are likely to drop slightly above 8.5 B in 2024. This firm currently falls under 'Large-Cap' category with a total capitalization of 15.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quest Diagnostics's market, we take the total number of its shares issued and multiply it by Quest Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.
Macroaxis Gross Profit
Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty
BioPlus Acquisition Corp (BIOS)
The entity has a beta of 0.0156. As returns on the market increase, BioPlus Acquisition's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioPlus Acquisition is expected to be smaller as well. The beta indicator helps investors understand whether BioPlus Acquisition moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if BioPlus deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns. The firm currently falls under 'Small-Cap' category with a current market capitalization of 208.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPlus Acquisition's market, we take the total number of its shares issued and multiply it by BioPlus Acquisition's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Addus HomeCare (ADUS)
The company has return on total asset (ROA) of 0.0618 % which means that it generated a profit of $0.0618 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0933 %, meaning that it created $0.0933 on every $100 dollars invested by stockholders. Addus HomeCare's management efficiency ratios could be used to measure how well Addus HomeCare manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.24 in 2024, whereas Return On Capital Employed is likely to drop 0.07 in 2024. At this time, Addus HomeCare's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 865.6 M in 2024, whereas Other Current Assets are likely to drop slightly above 11.4 M in 2024. The firm currently falls under 'Mid-Cap' category with a current market capitalization of 1.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Addus HomeCare's market, we take the total number of its shares issued and multiply it by Addus HomeCare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
The company has return on total asset (ROA) of 0.0612 % which means that it generated a profit of $0.0612 on every $100 spent on assets. This is way below average. Acadia Healthcare's management efficiency ratios could be used to measure how well Acadia Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.0067. In addition to that, Return On Capital Employed is expected to decline to 0.06. At present, Acadia Healthcare's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 52.5 M, whereas Total Assets are forecasted to decline to about 4.4 B. This firm currently falls under 'Mid-Cap' category with a current market capitalization of 6.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acadia Healthcare's market, we take the total number of its shares issued and multiply it by Acadia Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Acadia Healthcare shows a prevailing Real Value of $82.5 per share. The current price of the firm is $71.19. Our model approximates the value of Acadia Healthcare from analyzing the firm fundamentals such as return on equity of -0.0054, and Profit Margin of (0.01) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Natera Inc (NTRA)
The company has return on total asset (ROA) of (0.1967) % which means that it has lost $0.1967 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5911) %, meaning that it created substantial loss on money invested by shareholders. Natera's management efficiency ratios could be used to measure how well Natera manages its routine affairs as well as how well it operates its assets and liabilities. As of April 25, 2024, Return On Tangible Assets is expected to decline to -0.31. In addition to that, Return On Capital Employed is expected to decline to -0.41. At present, Natera's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 208.5 M, whereas Other Assets are forecasted to decline to about 11.3 M. The firm currently falls under 'Large-Cap' category with a current market capitalization of 11.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Natera's market, we take the total number of its shares issued and multiply it by Natera's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
464.09 Million
At present, Natera's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
LHC Group (LHCG)
The company has return on total asset (ROA) of 0.0312 % which means that it generated a profit of $0.0312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0486 %, meaning that it created $0.0486 on every $100 dollars invested by stockholders. LHC's management efficiency ratios could be used to measure how well LHC manages its routine affairs as well as how well it operates its assets and liabilities. The firm currently falls under 'Mid-Cap' category with a current market capitalization of 5.27 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LHC's market, we take the total number of its shares issued and multiply it by LHC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
National HealthCare (NHC)
The company has Return on Asset of 0.0248 % which means that on every $100 spent on assets, it made $0.0248 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.073 %, implying that it generated $0.073 on every 100 dollars invested. National HealthCare's management efficiency ratios could be used to measure how well National HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, National HealthCare's Return On Assets are projected to slightly decrease based on the last few years of reporting. At present, National HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.14, whereas Total Assets are forecasted to decline to about 772 M. The firm currently falls under 'Mid-Cap' category with a total capitalization of 1.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate National HealthCare's market, we take the total number of its shares issued and multiply it by National HealthCare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
76.5 Million
At present, National HealthCare's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
HCA Holdings (HCA)
HCA Holdings [HCA] is traded in USA and was established null. HCA Holdings is listed under Health Care Providers & Services category by Fama And French industry classification. The fund is classified under Health Care category within Health Care Providers & Services family. The entity is thematically classified as Obamacare Repeal. HCA Holdings currently have 56.21 B in assets under management (AUM). with the current yeild of 0.01%. At this time, the entity appears to be overvalued. HCA Holdings owns a latest Real Value of $304.59 per share. The recent price of the entity is $319.02. Our model calculates the value of HCA Holdings from evaluating the entity fundamentals such as Return On Asset of 0.11, shares outstanding of 264.48 M, and Operating Margin of 0.16 % as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage taking in undervalued equities and trading overvalued equities since, at some future date, asset prices and their ongoing real values will blend.
Quest Diagnostics Incorporated (DGX)
The company has Return on Asset of 0.0621 % which means that on every $100 spent on assets, it made $0.0621 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1462 %, implying that it generated $0.1462 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.14 in 2024. Return On Capital Employed is likely to drop to 0.10 in 2024. At this time, Quest Diagnostics' Other Assets are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.99 in 2024, whereas Total Assets are likely to drop slightly above 8.5 B in 2024. This firm currently falls under 'Large-Cap' category with a total capitalization of 15.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quest Diagnostics's market, we take the total number of its shares issued and multiply it by Quest Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Did you try this?
Run Portfolio Analyzer Now
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
